Taysha Gene Therapies, Inc.

NASDAQ:TSHA

2.21 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 157.688172.743124.429144.389164.27845.08363.42587.8834.30666.23996.63149.103188.785197.37228.684251.253278.63411.20
Short Term Investments 0000000000000000000
Cash and Short Term Investments 157.688172.743124.429144.389164.27845.08363.42587.8834.30666.23996.63149.103188.785197.37228.684251.253278.63411.20
Net Receivables 0000000000000000000
Inventory 0000000000000000000
Other Current Assets 3.8675.7273.5665.9287.5299.0328.9338.5378.69610.59610.26110.4991.7232.20210.9456.6260.6040.0990
Total Current Assets 161.555178.47129.916149.187171.80754.11572.35896.41743.00276.835106.891159.602197.17207.302239.629257.879279.23811.2990
Non-Current Assets:
Property, Plant & Equipment, Net 16.29119.48419.94720.40821.02124.48725.28925.90663.95461.01155.1250.6140.55333.8672.4970.2870.0280.0190
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 0000000-4.99200000000000
Long Term Investments 002.1512.1512.6372.6372.6372.6372.6372.6372.6372.6372.628000000
Tax Assets 00094.2630002.35500000000000
Other Non-Current Assets 2.3712.4390.9850.9850.3040.3041.3163.9531.8751.8491.3281.1070.6910.6910.7030.715000
Total Non-Current Assets 18.66221.92323.083117.80723.96227.42829.24229.85968.46665.49759.08554.35443.87234.5583.21.0020.0280.0190
Total Assets 180.217200.393152.999266.994195.76981.543101.6126.276111.468142.332165.976213.956241.042241.86242.829258.881279.26611.3180
Liabilities & Equity:
Current Liabilities:
Account Payables 4.9328.71810.386.3667.5210.7669.00210.94615.25123.96721.99721.76322.0516.3554.0831.9948.8371.250
Short Term Debt 01.7541.6961.6461.5381.6381.7521.52100000000017.2040
Tax Payables 0000000000000000000
Deferred Revenue 11.79513.58314.69518.10618.75920.24328.85133.557000000000-17.2040
Other Current Liabilities 12.60810.12111.86610.638152.63417.99414.8516.76617.88818.98626.6229.98321.16322.03614.8755.1352.7871.6360
Total Current Liabilities 29.33534.17638.63736.756180.45150.64154.45562.7933.13942.95348.61751.74643.21428.39118.9587.12911.62420.090
Non-Current Liabilities:
Long Term Debt 17.75155.96959.01159.46157.64957.88258.08958.40763.26963.18963.13863.09254.41926.20900000
Deferred Revenue Non-Current 00018.9532.9516.2120-2.35500000000000
Deferred Tax Liabilities Non-Current 00094.2630002.35500000000000
Other Non-Current Liabilities 44.3341.381.5021.5773.8323.9224.0044.133.9343.483.4963.7353.0150.7650.9990.45000
Total Non-Current Liabilities 62.08557.34960.513155.30164.43268.01662.09362.53767.20366.66966.63466.82757.43426.9740.9990.458.8371.250
Total Liabilities 91.4291.52599.15192.057244.883118.657116.548125.327100.342109.622115.251118.573100.64855.36519.9577.57911.62420.090
Equity:
Preferred Stock 0000000000000000018.0140
Common Stock 0.0020.0020.0020.0020.0020.0010.0010.0010.0010.001000000000
Retained Earnings -583.52-557.996-537.068-513.007-560.748-443.661-419.063-401.441-345.94-319.633-285.76-235.649-185.263-134.076-93.15-61.126-42.808-27.7660
Accumulated Other Comprehensive Income/Loss -2.3282.405-0.251-0000-000000-00-00-0-0.135
Other Total Stockholders Equity 674.643664.457591.166587.942511.632406.546404.114402.389357.065352.342336.485331.032325.657320.571316.022312.428310.4518.9940
Total Shareholders Equity 88.797108.86853.84974.937-49.114-37.114-14.9480.94911.12632.7150.72595.383140.394186.495222.872251.302267.642-8.772-0.135
Total Equity 88.797108.86853.84974.937-49.114-37.114-14.9480.94911.12632.7150.72595.383140.394186.495222.872251.302267.642-8.772-0.135
Total Liabilities & Shareholders Equity 180.217200.393152.999266.994195.76981.543101.6126.276111.468142.332165.976213.956241.042241.86242.829258.881279.26611.318-0.135